One speaker argued that general ophthalmologists could improve early diagnosis of glaucoma. Another said glaucoma is a complex disease that necessitates specialist-level knowledge. SEVILLE ...

Christine Funke, MD, discusses how the treatment of glaucoma has evolved in her decade of experience. Christine Funke, MD, glaucoma specialist at Barnet Dulaney Perkins Eye Center in Phoenix ...

There's going to be an industry symposium called SightLine, which is a new program. And alongside that, ASOA is doing a business of interventional glaucoma [event.] Abby Markward, MBA: The SightLine ...

A large new study has raised an important question about whether all heart attack survivors really need to stay on beta-blockers for years, especially if they don’t have heart failure.

Herein we report a 78-year-old female glaucoma patient who developed general weakness and acute respiratory failure, followed by cardiac arrest 1 day after taking acetazolamide. The patient was ...

As cardiovascular disease progresses, the issue of switching from one β blocker to another is an important consideration as to how to optimize the effectiveness of adrenergic blockade.

STAR-GLOBAL is an extension trial of the initial EU clinical trials investigating the long-term safety and efficacy of MINIject ® in patients with up to five-years of follow-up. Patients implanted ...

It can be difficult to diagnose dry eye properly because it’s one of many conditions that can make your eyes feel dry or uncomfortable. Consulting a qualified ophthalmologist or optometrist can ...

At close: April 22 at 4:00:00 PM EDT ...

a potassium-competitive acid blocker (P-CAB), in adults with erosive esophagitis and nonerosive reflux disease, respectively. Study participants (N=1250) in TRIUMpH-EE were randomly assigned to ...